Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Activated microglia do not form functional gap junctions in vivo.

Wasseff SK, Scherer SS.

J Neuroimmunol. 2014 Apr 15;269(1-2):90-3. doi: 10.1016/j.jneuroim.2014.02.005. Epub 2014 Feb 13.

2.

Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.

Takeuchi H, Mizoguchi H, Doi Y, Jin S, Noda M, Liang J, Li H, Zhou Y, Mori R, Yasuoka S, Li E, Parajuli B, Kawanokuchi J, Sonobe Y, Sato J, Yamanaka K, Sobue G, Mizuno T, Suzumura A.

PLoS One. 2011;6(6):e21108. doi: 10.1371/journal.pone.0021108. Epub 2011 Jun 21.

3.

GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.

Kamphuis W, Kooijman L, Orre M, Stassen O, Pekny M, Hol EM.

Glia. 2015 Jun;63(6):1036-56. doi: 10.1002/glia.22800. Epub 2015 Mar 2.

PMID:
25731615
4.

Injury Leads to the Appearance of Cells with Characteristics of Both Microglia and Astrocytes in Mouse and Human Brain.

Wilhelmsson U, Andersson D, de Pablo Y, Pekny R, Ståhlberg A, Mulder J, Mitsios N, Hortobágyi T, Pekny M, Pekna M.

Cereb Cortex. 2017 Jun 1;27(6):3360-3377. doi: 10.1093/cercor/bhx069.

PMID:
28398520
5.

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease.

Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J.

Nat Neurosci. 2010 Apr;13(4):411-3. doi: 10.1038/nn.2511. Epub 2010 Mar 21.

6.

Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity.

Umebayashi D, Natsume A, Takeuchi H, Hara M, Nishimura Y, Fukuyama R, Sumiyoshi N, Wakabayashi T.

J Neurotrauma. 2014 Dec 15;31(24):1967-74. doi: 10.1089/neu.2013.3223. Epub 2014 Sep 23.

7.

Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.

Damjanac M, Rioux Bilan A, Barrier L, Pontcharraud R, Anne C, Hugon J, Page G.

Brain Res. 2007 Jan 12;1128(1):40-9. Epub 2006 Nov 27.

PMID:
17125750
8.

Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha.

Eugenín EA, Eckardt D, Theis M, Willecke K, Bennett MV, Saez JC.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4190-5. Epub 2001 Mar 20.

9.

Glial connexin expression and function in the context of Alzheimer's disease.

Koulakoff A, Mei X, Orellana JA, Sáez JC, Giaume C.

Biochim Biophys Acta. 2012 Aug;1818(8):2048-57. doi: 10.1016/j.bbamem.2011.10.001. Epub 2011 Oct 7. Review.

10.

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.

Magga J, Puli L, Pihlaja R, Kanninen K, Neulamaa S, Malm T, Härtig W, Grosche J, Goldsteins G, Tanila H, Koistinaho J, Koistinaho M.

J Neuroinflammation. 2010 Dec 7;7:90. doi: 10.1186/1742-2094-7-90.

11.

Microglial activation in Alzheimer's disease.

Schlachetzki JC, Hüll M.

Curr Alzheimer Res. 2009 Dec;6(6):554-63. Review.

PMID:
19747160
12.

Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia.

Retamal MA, Froger N, Palacios-Prado N, Ezan P, Sáez PJ, Sáez JC, Giaume C.

J Neurosci. 2007 Dec 12;27(50):13781-92.

13.

The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.

Collins JM, King AE, Woodhouse A, Kirkcaldie MT, Vickers JC.

Exp Neurol. 2015 May;267:219-29. doi: 10.1016/j.expneurol.2015.02.034. Epub 2015 Mar 4.

PMID:
25747037
14.

Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.

Mewes A, Franke H, Singer D.

PLoS One. 2012;7(9):e45017. doi: 10.1371/journal.pone.0045017. Epub 2012 Sep 11.

15.

CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.

Tan J, Town T, Mori T, Wu Y, Saxe M, Crawford F, Mullan M.

J Neurosci. 2000 Oct 15;20(20):7587-94.

16.

Neuroprotective role of γ-enolase in microglia in a mouse model of Alzheimer's disease is regulated by cathepsin X.

Hafner A, Glavan G, Obermajer N, Živin M, Schliebs R, Kos J.

Aging Cell. 2013 Aug;12(4):604-14. doi: 10.1111/acel.12093. Epub 2013 May 27.

17.

Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.

Natunen T, Takalo M, Kemppainen S, Leskelä S, Marttinen M, Kurkinen KMA, Pursiheimo JP, Sarajärvi T, Viswanathan J, Gabbouj S, Solje E, Tahvanainen E, Pirttimäki T, Kurki M, Paananen J, Rauramaa T, Miettinen P, Mäkinen P, Leinonen V, Soininen H, Airenne K, Tanzi RE, Tanila H, Haapasalo A, Hiltunen M.

Neurobiol Dis. 2016 Jan;85:187-205. doi: 10.1016/j.nbd.2015.11.005. Epub 2015 Nov 10.

PMID:
26563932
18.

Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer's disease.

Baron R, Babcock AA, Nemirovsky A, Finsen B, Monsonego A.

Aging Cell. 2014 Aug;13(4):584-95. doi: 10.1111/acel.12210. Epub 2014 Mar 18.

19.

Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.

Rojanathammanee L, Floden AM, Manocha GD, Combs CK.

J Neuroinflammation. 2015 Mar 4;12:42. doi: 10.1186/s12974-015-0255-2.

20.

Supplemental Content

Support Center